Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: A comparative study with lauric acid

Published:November 26, 2013DOI:



      Propionibacterium acnes (P. acnes) is a commensal bacterium which is possibly involved in acne inflammation. The saturated fatty acid, lauric acid (C12:0) has been shown to possess antibacterial and anti-inflammatory properties against P. acnes. Little is known concerning the potential effects of its decanoic counterpart, capric acid (C10:0).


      To examine the antibacterial and anti-inflammatory activities of capric acid against P. acnes and to investigate the mechanism of the anti-inflammatory action.


      The antimicrobial activity of fatty acids was detected using the broth dilution method. An evaluation of P. acnes-induced ear edema in mice was conducted to evaluate the in vivo anti-inflammatory effect. To elucidate the in vitro anti-inflammatory effect, human SZ95 sebocytes and monocytic THP-1 cells were treated with P. acnes alone or in the presence of a fatty acid. The mRNA levels and secretion of pro-inflammatory cytokines were measured by qRT-PCR and enzyme immunoassay, respectively. NF-κB activation and MAPK expression were analyzed by ELISA and Western blot, respectively.


      Lauric acid had stronger antimicrobial activity against P. acnes than capric acid in vitro and in vivo. However, both fatty acids attenuated P. acnes-induced ear swelling in mice along with microabscess and significantly reduced interleukin (IL)-6 and CXCL8 (also known as IL-8) production in P. acnes-stimulated SZ95 sebocytes. P. acnes-induced mRNA levels and secretion of IL-8 and TNF-α in THP-1 cells were suppressed by both fatty acids, which inhibited NF-κB activation and the phosphorylation of MAP kinases.


      Our data demonstrate that both capric acid and lauric acid exert bactericidal and anti-inflammatory activities against P. acnes. The anti-inflammatory effect may partially occur through the inhibition of NF-κB activation and the phosphorylation of MAP kinases.


      To read this article in full you will need to make a payment


        • Webster G.F.
        Acne vulgaris.
        Brit Med J. 2002; 325: 475-479
        • Kim J.
        • Ochoa M.T.
        • Krutzik S.R.
        • Takeuchi O.
        • Uematsu S.
        • Legaspi A.J.
        • et al.
        Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses.
        J Immunol. 2002; 169: 1535-1541
        • Koreck A.
        • Pivarcsi A.
        • Dobozy A.
        • Kemény L.
        The role of innate immunity in the pathogenesis of acne.
        Dermatology. 2003; 206: 96-105
        • Kurokawa I.
        • Danby F.W.
        • Ju Q.
        • Wang X.
        • Xiang L.F.
        • Xia L.
        • et al.
        New developments in our understanding of acne pathogenesis and treatment.
        Exp Dermatol. 2009; 18: 821-832
        • Grange P.A.
        • Raingeaud J.
        • Calvez V.
        • Dupin N.
        Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-κB and MAPK pathways.
        J Dermatol Sci. 2009; 56: 106-112
        • Chen Q.J.
        • Koga T.
        • Uchi H.
        • Hara H.
        • Terao H.
        • Moroi Y.
        • et al.
        Propionibacterium acnes-induced IL-8 production may be mediated by NF-κB activation in human monocytes.
        J Dermatol Sci. 2002; 29: 97-103
        • Vowels B.R.
        • Yang S.
        • Leyden J.J.
        Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implication for chronic inflammatory acne.
        Infect Immun. 1995; 63: 3158-3165
        • Hsu C.
        • Tsai T.H.
        • Li Y.Y.
        • Wu W.H.
        • Huang C.J.
        • Tsai P.J.
        Wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) extract and its bioactive components suppress Propionibacterium acnes-induced inflammation.
        Food Chem. 2012; 135: 976-984
        • Ottaviani M.
        • Camera E.
        • Picardo M.
        Lipid mediators in acne.
        Meditors Inflamm. 2010; 7 (pii: 858176)
        • Makrantonaki E.
        • Ganceviciene R.
        • Zouboulis C.C.
        An update on the role of the sebaceous gland in the pathogenesis of acne.
        Dermatoendocrinol. 2011; 3: 41-49
        • Alestas T.
        • Ganceviciene R.
        • Fimmel S.
        • Muller-Decker K.
        • Zouboulis C.C.
        Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands.
        J Mol Med. 2006; 84: 75-87
        • Wu X.L.
        • Schauss A.G.
        Mitigation of inflammation with foods.
        J Agric Food Chem. 2012; 60: 6703-6717
        • Taylor M.
        • Gonzalez M.
        • Porter R.
        Pathways to inflammation: acne pathophysiology.
        Eur J Dermatol. 2011; 21: 323-333
        • Sprong R.C.
        • Hulstein M.F.E.
        • Meer R.V.
        Bactericidal activities of milk lipids.
        Antimicrob Agents Chemother. 2001; 45: 1298-1301
        • Desbois A.P.
        • Smith V.J.
        Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential.
        Appl Microbiol Biotechnol. 2010; 85: 1629-1642
        • Nakatsuji T.
        • Kao M.C.
        • Fang J.Y.
        • Zouboulis C.C.
        • Zhang L.
        • Gallo R.L.
        • et al.
        Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.
        J Invest Dermatol. 2009; 129: 2480-2488
        • Zouboulis C.C.
        • Seltmann H.
        • Neitzel H.
        • Orfanos C.E.
        Establishment and characterization of an immortalized human sebaceous gland cell line SZ95.
        J Invest Dermatol. 1999; 113: 1011-1120
        • Tsai T.H.
        • Tsai T.H.
        • Wu W.H.
        • Tseng T.P.
        • Tsai P.J.
        In vitro antimicrobial and anti-inflammatory effects of herbs against Propionibacterium acnes.
        Food Chem. 2010; 119: 964-968
        • Yang D.
        • Pornpattananangkul D.
        • Nakatsuji T.
        • Chan M.
        • Carson D.
        • Huang C.M.
        • et al.
        The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes.
        Biomaterials. 2009; 30: 6035-6040
        • Chang K.L.
        • Chen C.H.
        • Hsieh M.F.
        • Huang C.M.
        The nanoparticles for combating acne vulgairs: in-vitro efficacy of lauric acid-loaded PCL-PEG-PCL on Propionbactrium acnes.
        in: 2010 International conference on nanotechnology and biosensors. IPCBEE 2. 2011: 157-161
        • Ko S.H.L.
        • Heczko P.B.
        • Pulverer G.
        Differential susceptibility of Propionibacterium acnes, P. granulosum and P. avidum to free fatty acids.
        J Invest Dermatol. 1978; 71: 363-365
        • Wu W.H.
        • Lin B.Y.
        • Kuo Y.H.
        • Huang C.J.
        Triglycerides constituted of short and medium chain fatty acids and dicarboxylic acids in Momordica charantia, as well as capric acid, inhibit PGE2 production in RAW264.7 macrophages.
        Food Chem. 2009; 117: 306-311
        • Park E.J.
        • Kim S.A.
        • Choi Y.M.
        • Kwon H.K.
        • Shim W.
        • Lee G.
        • et al.
        Capric acid inhibits NO production and STAT3 activation during LPS-induced osteoclastogenesis.
        PLoS ONE. 2011; 6: e27739
        • Kim J.
        Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses.
        Dermatology. 2005; 211: 193-198
        • Nagy I.
        • Pivarcsi A.
        • Kis K.
        • Koreck A.
        • Bodai L.
        • McDowell A.
        • et al.
        Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes.
        Microbes Infect. 2006; 8: 2195-2205
        • Hoch R.C.
        • Scraufstätter I.U.
        • Cochrane C.G.
        In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors.
        J Lab Clin Med. 1996; 128: 134-145
        • Sugisaki H.
        • Yamanaka K.
        • Kakeda M.
        • Kitagawa H.
        • Tanaka K.
        • Watanabe K.
        • et al.
        Increased interferon-γ, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
        J Dermatol Sci. 2009; 55: 47-52
        • Feghali C.A.
        • Wright T.M.
        Cytokines in acute and chronic inflammation.
        Front Biosci. 1997; 2: d12-d26
        • Barnes P.J.
        Nuclear factor-κB.
        Int J Biochem Cell Biol. 1997; 29: 867-870
        • Kang S.
        • Cho S.
        • Chung J.H.
        • Hammerberg C.
        • Fisher G.J.
        • Voorhees J.J.
        Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-κB and activator protein-1 in inflammatory acne lesions in vivo.
        Am J Pathol. 2005; 166: 1691-1699
        • Gaudreault E.
        • Gosselin J.
        Leukotriene B4 potentiates CpG signaling for enhanced cytokine secretion by human leukocytes.
        J Immunol. 2009; 183: 2650-2658
        • Nakatsuji T.
        • Liu Y.T.
        • Huang C.P.
        • Zouboulis C.C.
        • Gallo R.L.
        • Huang C.M.
        Antibodies elicited by inactivated P. acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris.
        J Invest Dermatol. 2008; 128: 2451-2457